Scholarly Index
Mario Boccadoro
European Heart Network; 46,783 total citations; 1,066 total publications; best world rank #42
European Heart Network
46,783Total citations
1,066Total publications
98H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Multiple Myeloma Research and Treatments | Lifetime | 42 | BE 1 | 99.72 |
| Peptidase Inhibition and Analysis | Lifetime | 123 | BE 4 | 99.41 |
| Protein Degradation and Inhibitors | Lifetime | 51 | BE 1 | 99.50 |
| Cancer Treatment and Pharmacology | Lifetime | 173 | BE 5 | 99.45 |
| Ubiquitin and proteasome pathways | Lifetime | 456 | BE 3 | 97.95 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 765 | BE 9 | 98.13 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 272 | BE 5 | 97.90 |
| Cancer therapeutics and mechanisms | Lifetime | 606 | BE 6 | 96.97 |
| Hematological disorders and diagnostics | Lifetime | 442 | BE 16 | 94.26 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 478 | BE 6 | 95.04 |
| Blood disorders and treatments | Lifetime | 883 | BE 9 | 91.91 |
| Chemokine receptors and signaling | Lifetime | 961 | BE 24 | 89.54 |
| Multiple Myeloma Research and Treatments | 2021-2025 | 84 | BE 1 | 98.86 |
| Protein Degradation and Inhibitors | 2021-2025 | 104 | BE 1 | 97.70 |
| Peptidase Inhibition and Analysis | 2021-2025 | 285 | BE 1 | 94.09 |